siRNA targeting superoxide dismutase 1 (SOD1)

siRNA targeting fructose-1,6-bisphosphatase 1 (FBP1)

siRNA targeting amyloid beta (A4) precursor protein (APP)

siRNA targeting glucagon receptor (GCGR)

siRNA targeting beta secretase (BACE)

siRNA targeting apolipoprotein B (APOB)

siRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)

Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same

RECOMBINANT EUKARYOTIC CELLS STABLY EXPRESSING (SID-1) PROTEINS FOR HIGH THROUGHPUT GENE SCREENING

CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY

Functional and hyperfunctional siRNA directed against Bcl-2

Functional and hyperfunctional siRNA directed against Bcl-2

Peptide Nucleic Acid Conjugates and Uses Thereof

siRNA targeting kinases

siRNA targeting TNFalpha

Functional and hyperfunctional siRNA directed against Bcl-2

siRNA targeting deubiqutination enzymes

Small Interfering Rna and Pharmaceutical Composition for Treatment of Hepatitis B Comprising the Same

Functional and hyperfunctional siRNA directed against Bcl-2

Functional and hyperfunctional siRNA directed against Bcl-2

Functional and hyperfunctional siRNA directed against Bcl-2

Functional and hyperfunctional siRNA directed against Bcl-2

siRNA targeting complement component 3 (C3)

siRNA targeting secreted frizzled-related protein 1 (sFRP1)

SiRNA targeting intercellular adhesion molecule 1 (ICAM1)

MODULATION OF GENE EXPRESSION USING DNA-RNA HYBRIDS

siRNA targeting transient receptor potential cation channel, subfamily V, member 1 (TRPV1)

siRNA targeting phosphoinositide-3-kinase, class 2, beta polypeptide (PIK3C2B)

Duplex oligonucleotide complexes and methods for gene silencing by RNA interference

VEHICLE FOR THE TRANSPORT OF A CHOSEN MOLECULE TO A CELL

siRNA targeting carbonic anhydrase 4(CA4)

Methods and compositions for inhibiting the function of polynucleotide sequences

Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi

siRNA targeting nuclear receptors

DICER SUBSTRATE RNA PEPTIDE CONJUGATES AND METHODS FOR RNA THERAPEUTICS

siRNA targeting proteasome 26S subunit, non-ATPase, 10 (Gankyrin or PSMD10)

siRNA targeting ubiquitin ligases

Cytoplasmic Localization Dna and Rna

RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines

siRNA targeting cyclin dependent kinase 11 (CDK11)

Conjugate of Peo and Double Stranded Nucleic Acid

pRNA chimera

Methods and compositions for amplification and detection of MicroRNAs

Methods and compositions involving miRNA and miRNA inhibitor molecules

siRNA targeting platelet-derived growth factor receptor beta polypeptide (PDGFR)

Three-component biosensors for detecting macromolecules and other analytes

POLYCYCLIC SUGAR SURROGATE-CONTAINING OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATION

siRNA targeting neuropeptide Y (NPY)

RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS

Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

Polycationic compositions for cellular delivery of polynucleotides

2'-MODIFIED OLIGONUCLEOTIDES

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

siRNA targeting sodium channel, voltage-gated, type X, alpha (SCN10A)

siRNA targeting vascular endothelial growth factor (VEGF)

Methods and compositions involving microRNA

Cell-based RNA interference and related methods and compositions

Methods and Compositions for Use in Preparing Hairpin Rnas

siRNA targeting connective tissue growth factor (CTGF)

Cochleate compositions directed against expression of proteins

Methods, libraries and computer program products for determining whether siRNA induced phenotypes are due to off-target effects

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

Method for manufacturing specific binding molecules against selected target molecules, kit, and binding molecules

siRNA targeting vacuolar ATPase

MicroRNA biomarkers for human breast and lung cancer

BACKBONE MODIFICATIONS TO MODULATE OLIGONUCLEOTIDE TARGETING IN VIVO

Cancer Therapeutic

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

siRNA targeting minichromosome maintenance deficient 5 (MCM5)

COMPLEXES AND METHODS OF FORMING COMPLEXES OF RIBONUCLEIC ACIDS AND PEPTIDES

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

siRNA targeting minichromosome maintenance deficient 6 (MCM6)

SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof

COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY

Kits and methods for generating 5' capped RNA

siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)

siRNA targeting dual specificity phosphate 5 (DUSP5)

CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY

RNA amidates and thioamidates for RNAi

Therapeutic compositions

Double-stranded ribonucleic acid with increased effectiveness in an organism

MicroRNA motifs

Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent

Rybozyme-catalyzed insertion of targeted sequences into RNA

FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA

Stabilized siRNAs as transfection controls and silencing reagents

Multitargeting interfering RNAs having two active strands and methods for their design and use

Transcatheter tumor immunoembolization

siRNA targeting polo-like kinase-1 (PLK-1)

siRNA targeting testes development-related NYD-SP21 (NYD-SP21)

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

Antisense restenosis composition and method

siRNA targeting RAD1 homolog (RAD1)

siRNA targeting pituitary tumor-transforming 1 (PTTG1)

siRNA targeting minichromosome maintenance deficient 7 (MCM7)

siRNA targeting MAD2 mitotic arrest deficient-like (MAD2L2)

siRNA targeting centromere protein E, 312kDa (CENPE)

siRNA targeting EPH receptor A4 (EPHA4)

Antisense agents combining strongly bound base-modified oligonucleotide and artificial nuclease

Compositions and methods for enhancing discriminatory RNA interference

SELECTING AND STABILIZING dsRNA CONSTRUCTS

Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNA

siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)

siRNA targeting serine/threonine kinase 22B (STK22B)

siRNA targeting minichromosome maintenance deficient 2, mitotin (MCM2)

siRNA targeting EPH receptor A3 (EPHA3)

siRNA targeting discoidin domain receptor family, member 1 (DDR1)

siRNA targeting cell division cycle 6 homolog (CDC6)

siRNA targeting spectrin SH3 domain binding protein 1 (SSH3BP1)

COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX

Activatable Ribozymal Purification Constructs and Methods of Use

siRNA targeting WEE1 homolog (WEE1)

Modulation of immune response and inflammation by targeting hypoxia inducible factors

Soluble TNF receptors and their use in treatment of disease

Compositions and methods for altering RNAi

Arrays containing cleavable RNAi molecules

Individualized cancer therapy

siRNA targeting phosphoinositide-3-kinase, class 2, alpha polypeptide (PIK3C2A)

siRNA targeting coatomer protein complex, subunit beta 2 (COPB2)

Antisense compounds targeted to connexins and methods of use thereof

Biodegradable cationic polymers

siRNA targeting chemokine (C-X-C motif) receptor 4 (CXCR4)

Methods and compositions for inhibiting the function of polynucleotide sequences

siRNA targeting cell division cycle 2-like 5(CDC2L5)

Methods and compositions for inhibiting the function of polynucleotide sequences

METHODS FOR DIRECTING DNA METHYLATION IN MAMMALIAN CELLS USING HOMOLOGOUS, SHORT DOUBLE STRANDED RNAS

Multicomponent nucleic acid enzymes and methods for their use

Method for preparing short hairpin RNA from CDNA

CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY

siRNA targeting gremlin

Vehicle for the Transport of a Chosen Molecule to a Cell

VEHICLE TO TRANSPORT A DNA-MODIFYING ENZYME TO A GENOME

Protection of Biologically Active Molecules Using Amphiphiles

siRNA targeting azurocidin 1 (Cartionic Antimicrobial protein 37)

Methods and compositions for inhibiting the function of polynucleotide sequences

Modified triple-helix forming oligonucleotides for targeted mutagenesis

Polypeptide Having Rnase III Activity

Methods, libraries and computer program products for gene silencing with reduced off-target effects

Method for identifying drug-sensitizing antisense DNA fragments and use thereof

MicroRNA precursors

METHOD TO INDUCE RNAI IN PROKARYOTIC ORGANISMS

siRNA targeting cell division cycle 25 (CDC25C)

siRNA targeting calcium/calmodulin dependent protein kinase IV (CAMK4)

Method of selecting targets for gene silencing by RNA interference

Functional and hyperfunctional siRNA

siRNA targeting minichromosome maintenance deficient 4 (MCM4)

Interfering Rna Duplex Having Blunt-Ends And 3'-Modifications

Promoters for RNA interference

Data correction apparatus, data correction method, magnetic resonance imaging apparatus and X-ray CT apparatus

Pharmaceutical composition

Short interfering RNA (siRNA) analogues

siRNA targeting cell division cycle 20 homolog (CDC20)

siRNA targeting insulin-like growth factor 1 receptor (IGF-1R)

siRNA targeting connexin 43

siRNA targeting HtrA serine peptidase 1

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)

Methods, agents, and compound screening assays for inducing differentiation of undifferentiatied mammalian cells into osteoblasts

siRNA targeting testis-specific serine kinase 4

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Protected monomers

MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna

Modified polynucleotides for use in rna interference

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

MICRORNAS AND RELATED NUCLEIC ACIDS

Small interfering RNA libraries and methods of synthesis and use

Method for evaluating rnai activity and mirna activity

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Methods and compositions for treating neurological disease

Methods and sequences to preferentially suppress expression of mutated huntingtin

Methods and compositions involving microRNA

Compositions and methods for generating short double-stranded RNA using mutated RNAse III

System and method for identification of MicroRNA target sites and corresponding targeting MicroRNA sequences

siRNA targeting spleen tyrosine kinase

siRNA targeting aquaporin 4

siRNA targeting cAMP-specific phosphodiesterase 4D

Method of producing short hairpin library

Shielded micelles for polynucleotide delivery

Modified siRNA molecules and uses thereof

Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis

Antisense antibacterial method and compound

siRNA targeting histamine receptor H1

siRNA targeting TIE-2

siRNA targeting hypoxia-inducible factor 1

siRNA targeting ras-related nuclear protein

Inhibition of gene expression by delivery of polynucleotides to animal cells in vivo

Universal target sequences for siRNA gene silencing

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Replication competent viruses capable of silencing virus inhibitory factor expression

Gene blocking method

Modulation of gene expression by oligomers targeted to chromosomal DNA

RNA interference

Small regulatory RNAs and methods of use

Splice switch oligomers for TNF superfamily receptors and their use in treatment of disease

Methods and compositions for treating neurological disease

Gene expression suppression agents

Polynucleotides capable of target-depedent circularization and topological linkage

Small interfering RNA mediated transcriptional gene silencing in mammalian cells

siRNA targeting carbonic anhydrase II

Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs

Nanoparticle delivery systems and methods of use thereof

siRNA targeting MCL1

RNA interference mediating small RNA molecules

Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Method for changing genetic properties of eukaryotic organism

siRNA targeting tumor necrosis factor superfamily member 1A

siRNA targeting complement factor B

siRNA targeting BCL2L1

siRNA targeting KRAS

Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences

Human microRNA targets in HIV genome and a method of identification thereof

Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method

FERRITIN AS A THERAPEUTIC TARGET IN ABNORMAL CELLS

Multiple RNAi expression cassettes for simultaneous delivery of RNAi agents related to heterozygotic expression patterns

Formulations comprising antisense nucleotides to connexins

siRNA targeting survivin

Formulations comprising antisense nucleotides to connexins

Formulations comprising antisense nucleotides to connexins

Oligonucleotide analogues incorporating 5-aza-cytosine therein

Formulations comprising antisense nucleotides to connexins

Aptamer medicinal chemistry

Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS

Formulations comprising antisense nucleotides to connexins

Pure miRNA Sample Preparation Method

Micrornas and uses thereof

Methods for producing microRNAs

Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite

Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof

Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof

Functional and hyperfunctional siRNA

Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use

Formulations comprising antisense nucleotides to connexins

ES cells having enhanced RNAi effect

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

Functional and hyperfunctional siRNA

Vaccinia virus-related nucleic acids and microRNA

Methods and compositions for silencing genes without inducing toxicity

Small interfering RNA with improved activity

GLUCOSE TRANSPORT-RELATED GENES, POLYPEPTIDES, AND METHODS OF USE THEREOF

Method and systems for identifying micro-RNA targets and synthesizing novel micro-RNAs and uses of the same

RNAi expression constructs

Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase

Methods and compositions for RNA interference

Nucleotides for prevention and treatment of bacterial and fungal pathologies

Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation

Method of treatment of RNA sample

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Method and means for treatment of osteoarthritis

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

Vectorization of dsRNA by cationic particles and topical use

Viral and viral associated miRNAs and uses thereof

Targets for tumor growth inhibition

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Dual functional oligonucleotides for use as anti-viral agents

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Methods for determining specificity of RNA silencing and for genetic analysis of the silenced gene or protein

Short interfering nucleic acid hybrids and methods thereof

RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides

Oligonucleotides comprising a non-phosphate backbone linkage

Compositions and methods for combined therapy of disease

Transgenic plant-derived siRNAs for suppression of influenza virus propagation in mammalian cells

Combinatorial selection of phosphorothioate aptamers for RNases

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Staple type oligonucleotide and drug comprising the same

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases

Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence processing method on comp

Antisense antiviral compound and method for treating ssRNA viral infection

Small interference RNA gene therapy

Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics

System and method for identification of MicroRNA precursor sequences and corresponding mature MicroRNA sequences from genomic sequences

Methods and constructs for evaluation of rnai targets and effector molecules

Methods of producing competitive aptamer fret reagents and assays

Methods of producing intrachain fluorophore-quencher FRET-aptamers and assays

Oligomeric compounds and compositions for use in modulation of pri-mirnas

Retroviral vectors for delivery of interfering RNA

Methods of identifying aberrant RNA or RNA targeted for cleavage by miRNA or siRNA